Search


Current filters:

Clear current filters  or Add more filters

View Option



Results 31-40 of 84 (Search time: 0.004 seconds).

  Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin (Journal article)

  Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG) (Journal article)

  Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer (Journal article)

  New evidence that tamoxifen does not induce osteoporosis: a nuclear activation analysis and absorptiometry study (Journal article)

  The Value of Neuroendocrine Markers in Nonsmall Cell Lung-Cancer - a Comparative Immunohistopathologic Study (Journal article)

  Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups (Journal article)

  Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (Journal article)

  Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin (Journal article)

  Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study (Journal article)

  Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration (Journal article)